Technological Innovations in Healthcare Industry
By Manish Kurhekar and Joydip Ghoshal
TIM methodology helps one outcompete change in a very scientific manner
Every hospital wants to be on top in terms of revenue and quality of care. It is tough enough to get to the top, but tougher still to stay there.Hospital Performance Management (HPM) allows management to identify areas for performance improvements, plan systematic performance
This IDC Manufacturing Insights Perspective reviews the Infosys Confluence 2016 conference that
was held April 27–29, 2016, in San Francisco. Renew and new has been the driving mantra for Infosys since Vishal Sikka came onboard as CEO 20 months ago. After a rough five-year stretch before Sikka joined because of the financial crash of 2008, the global economic slowdown, and reorganization, the ship has righted, so to speak, with 9% growth YoY for 2015–2016, $9.5 billion in revenue in FY16, and continued expansion of consulting, design, and software capabilities.
In Mysore, India, on one of the world’s largest corporate campuses, 3,000 employees of Infosys Technologies, Limited watched, waited, and cheered. Chairman N.R. Narayana Murthy had just pressed an orange button on his podium. On cue, half a world away, trading commenced on the NASDAQ.
What is the most important problem that an enterprise faces? What is it that all of us constantly worry about? How can we bring artificial intelligence (AI) to solve problems? In this video, Vishal Sikka, CEO and Managing Director, Infosys talks about the importance of the continuous reinvention of landscape and systems. He states, “An AI software platform can help us automate and lower the costs of maintenance of operations.” Vishal also emphasizes, “AI can help us codify and capture the knowledge that sits inside our systems and processes, and capture it across generations of people and technology.”
Infosys lagged, but only a bit, in 1QFY17. Investor expectations are now closer to reality (our USD revenue estimates stand moderated by 1.3/1.7% for FY17/18E). The FY17 guidance downgrade is largely attributable to the vertical-specific 1Q shortfall in Life Sciences (LS) and Energy & Utilities (E&U).